DEVICE CATEGORY · QSK
Hybrid Stent Graft, Thoracic Aortic Lesion Treatment
Repair or replacement of damaged or diseased vessel of the aortic arch and descending thoracic aorta, with or without involvement of ascending aorta, using vascular grafts and/or stent grafts placed during open surgical repair.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Thoraflex HybridP210006/S018 | Vascutek, Ltd. | PMA supplement | Sep 8, 2026 | FDA |
AMDS Hybrid ProsthesisP250055 | Artivion, Inc | PMA approval | Jun 26, 2026 | FDA |
Thoraflex HybridP210006/S019 | Vascutek, Ltd. | PMA supplement | Jun 24, 2026 | FDA |
Thoraflex HybridP210006/S017 | Vascutek, Ltd. | PMA supplement | Apr 20, 2026 | FDA |
Thoraflex HybridP210006/S016 | Vascutek, Ltd. | PMA supplement | Jan 29, 2026 | FDA |
Thoraflex HybridP210006/S015 | Vascutek, Ltd. | PMA supplement | Oct 29, 2025 | FDA |
Thoraflex HybridP210006/S014 | Vascutek, Ltd. | PMA supplement | Oct 16, 2025 | FDA |
Thoraflex HybridP210006/S013 | Vascutek, Ltd. | PMA supplement | Jul 30, 2025 | FDA |
Thoraflex HybridP210006 | Vascutek, Ltd. | PMA approval | Apr 19, 2022 | FDA |
Source information
Follow the FDA links to view the original records.






